Inovio Pharmaceuticals
INO
#8897
Rank
C$0.19 B
Marketcap
C$2.86
Share price
2.48%
Change (1 day)
-49.27%
Change (1 year)

P/S ratio for Inovio Pharmaceuticals (INO)

P/S ratio as of December 2025 (TTM): 765

According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -18.1. At the end of 2025 the company had a P/S ratio of 723.

P/S ratio history for Inovio Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
2025723133.15%
202431085.27%
2023167341.21%
202237.9-93.59%
2021592192.41%
2020202148.69%
201981.3537.59%
201812.844.44%
20178.83-39.22%
201614.521.49%
201512.0-77.57%
201453.317.75%
201345.3158.75%
201217.5214.73%
20115.56-71.71%
201019.753.06%
200912.817.71%
200810.930.14%
20078.38-75.2%
200633.8176.32%
200512.2-80.32%
200462.2-93.71%
20039881227.56%
200274.52126.05%
20013.34

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.36-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.29-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
14.7-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4.53-99.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
3.89-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2.30-99.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5.18-99.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA